multianalyte immunoassay
Recently Published Documents


TOTAL DOCUMENTS

20
(FIVE YEARS 1)

H-INDEX

10
(FIVE YEARS 1)

2018 ◽  
Vol 90 (4) ◽  
pp. 2716-2724 ◽  
Author(s):  
Lanteng Wang ◽  
Wenmeng Jiang ◽  
Xing Shen ◽  
Xiangmei Li ◽  
Xin-an Huang ◽  
...  

Author(s):  
Huangxian Ju ◽  
Guosong Lai ◽  
Feng Yan

2014 ◽  
Vol 42 (6) ◽  
pp. 817-823 ◽  
Author(s):  
Tian-Hua LI ◽  
Ning GAN ◽  
Da-Zhen WU ◽  
Hai-Juan JIN ◽  
Yu-Ting CAO ◽  
...  

The Analyst ◽  
2009 ◽  
Vol 134 (11) ◽  
pp. 2246 ◽  
Author(s):  
Hongyan Kang ◽  
Juru Miao ◽  
Zhijuan Cao ◽  
Jianzhong Lu

2007 ◽  
Vol 53 (8) ◽  
pp. 1495-1502 ◽  
Author(s):  
Jie Wu ◽  
Feng Yan ◽  
Jinhai Tang ◽  
Chun Zhai ◽  
Huangxian Ju

Abstract Background: Automated and convenient multianalyte detection with high throughput is increasingly needed in clinical diagnosis. We developed a disposable 4-by-2 array for programmed simultaneous amperometric immunoassay of 4 tumor markers. Methods: We used a screen-printed technique, 1-step immobilization method, and flow injection technique. We immobilized carcinoembryonic antigen, α-fetoprotein, β-human choriogonadotropin, and carcinoma antigen 125 as model analytes in a redox mediator–grafted, biopolymer-modified, screen-printed carbon electrode array to capture corresponding horseradish peroxidase-labeled antibodies in competitive immunoreactions. The simultaneous multianalyte immunoassay was automatically carried out to amperometrically monitor the mediator-catalyzed enzymatic response to hydrogen peroxide, which decreased in proportion to the concentrations of analytes in samples. Results: The multianalyte immunosensor array had a throughput of 60 samples/h and allowed simultaneous detection of carcinoembryonic antigen, α-fetoprotein, β-human choriogonadotropin, and carcinoma antigen 125 in clinical serum samples with concentrations up to 188 μg/L, 250 μg/L, 266 IU/L, and 334 kIU/L, respectively. The detection limits (limits of the blank, mean of blank plus 3 SD) were 1.1 μg/L, 1.7 μg/L, 1.2 IU/L, and 1.7 kIU/L. The inter- and intraassay imprecision (CVs) of the immunosensor arrays were <7.8% and <9.0%, respectively. The immunosensor arrays were stable for 28 days. Conclusions: This newly constructed immunosensor array provides a simple, automated, simultaneous multianalyte immunoassay with high throughput, short analytical time, and sufficiently low detection limits for clinical application. This method offers the capability of miniaturizing the multianalyte detection device.


Sign in / Sign up

Export Citation Format

Share Document